SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-23-108431
Filing Date
2023-04-20
Accepted
2023-04-20 16:58:06
Documents
19
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d498919d10ka.htm   iXBRL 10-K/A 386483
2 EX-31.3 d498919dex313.htm EX-31.3 3381
3 EX-31.4 d498919dex314.htm EX-31.4 3470
9 GRAPHIC g498919g01p18.jpg GRAPHIC 44367
10 GRAPHIC g498919g02p18.jpg GRAPHIC 71300
  Complete submission text file 0001193125-23-108431.txt   936119

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nerv-20221231.xsd EX-101.SCH 5347
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20221231_cal.xml EX-101.CAL 975
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20221231_def.xml EX-101.DEF 3409
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20221231_lab.xml EX-101.LAB 22445
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20221231_pre.xml EX-101.PRE 17977
13 EXTRACTED XBRL INSTANCE DOCUMENT d498919d10ka_htm.xml XML 8706
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36517 | Film No.: 23833803
SIC: 2834 Pharmaceutical Preparations